These compounds may interact with:
Ribosomal protein S6 kinase alpha-3
Potentially involved in: intellectual disability; coffin-lowry syndrome; kidney cancer; carcinoma; liver cancer; cancer; partington syndrome; hemorrhoid; bone diseases, developmental; cutis laxa; epilepsy; flatfoot; sensorineural hearing loss (disorder); hernia, inguinal; orbital separation excessive; hypodontia; kyphosis deformity of spine; language delay; macrostomia; malocclusion
Disease data sourced from Pharos.